HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013133 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Rivka Shem-Tov und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Infectious Diseases Research Laboratory, Sheba Medical Center, Tel-Hashomer, Israel. Hauptthemen laut MEDLINE: Bacterial Proteins, Transcription Factors, Typhoid Fever, Salmonella paratyphi A. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German-Israeli Foundation for Scientific Research and Development (GIF), Research Cooperation Lower Saxony – Israel (The Volkswagen Foundation), Israel Science Foundation (ISF).
Abstract (Originalsprache)
Salmonella enterica is a diverse bacterial pathogen consisting of both typhoidal and nontyphoidal clinically distinct serovars. While typhoidal serovars cause in humans a systemic life-threatening enteric fever, nontyphoidal Salmonella (NTS) usually provoke a localized self-limiting gastroenteritis. Factors responsible for the different diseases caused by distinct Salmonella serovars are still poorly understood. Here, we show that at elevated physiological temperature, manifested during enteric fever (39–40°C), the transcription of the flagellar regulon, its protein translation, and flagella-mediated motility are all repressed in the typhoidal serovar, S . Paratyphi A. In contrast, the NTS representative serovar, S . Typhimurium, maintains similar or even higher levels of flagellar genes transcription, translation, and motility at 40°C relative to 37°C. By using a temperature-responsive chromogenic reporter system in conjunction with a dense transposon mutagenesis screen we found that under elevated temperature, HilE negatively regulates S . Paratyphi A motility in a HilD-dependent manner. Because HilD is required for the transcriptional activation of flhDC , encoding the master regulator of the Salmonella flagellar-chemotaxis regulon , null deletion of hilE leads to motility upregulation at elevated temperature and the loss of motility thermoregulation in S . Paratyphi A . Moreover, we show that a HilE-mediated motility thermoregulation is common to other typhoidal serovars, including S . Typhi and S . Sendai, but not to S . Paratyphi B, nor to various NTS serovars. Interestingly, the absence of HilE also leads to a hyper-uptake of S . Paratyphi A by THP-1 human macrophages at 40°C, but not at 37°C. Based on these results, we propose that HilE plays a unique role in motility thermoregulation in typhoidal Salmonella in a way that may restrain systemic dissemination of the pathogen via professional phagocytes, during the acute phase of enteric fever.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Infectious Diseases Research Laboratory, Sheba Medical Center, Tel-Hashomer, Israel.
- Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Clinical Microbiology and Immunology, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Ohad Gal-Mor
Förderung
- German-Israeli Foundation for Scientific Research and Development (GIF)
- Research Cooperation Lower Saxony – Israel (The Volkswagen Foundation)
- Israel Science Foundation (ISF)
- The Research Cooperation Lower Saxony – Israel
Zitieren
APA
Shem-Tov, R., & Gal-Mor, O. (2025). HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013133
Vancouver
Shem-Tov R, Gal-Mor O. HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013133
BibTeX
@article{ShemTov2025,
author = {Shem-Tov, Rivka and Gal-Mor, Ohad},
title = {HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013133}
}
EUVIMED